Assessment of Peripheral Veins Doppler Ultrasound for Diagnosis of Acute Right Heart Failure in Suspicion or Follow-up of Pulmonary Hypertension
CODOVEIN
1 other identifier
interventional
103
1 country
1
Brief Summary
Occurrence of acute right heart failure (ARHF) remains common during pulmonary hypertension (PH). Right atrial pressure (RAP) invasive measurement is the gold standard to diagnose ARHF in order to improve diuretic treatment management. Existence of indirect signs of ARHF on venous Doppler ultrasound waveform has long been described, but correlation with RAP has not been properly established yet. It is the aim of our study in order to obtain an additional tool to manage ARHF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedStudy Start
First participant enrolled
June 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2022
CompletedDecember 1, 2022
November 1, 2022
1.4 years
March 8, 2021
November 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity, specificity, positive and negative likelihood ratios of venous stasis index
Sensitivity, specificity, positive and negative likelihood ratios of venous stasis index\*, measured by Pulsed Doppler on common femoral veins, as a diagnostic criterion for ARHF (defined by RAP ≥10 mm Hg). \* Defined as duration of non-anterograde venous flow during 3 seconds/ 3 seconds
Inclusion day within 4 hours before the right heart catheterization
Study Arms (1)
Peripheral veins Doppler ultrasound
EXPERIMENTALInterventions
Patients undergoing a right heart catheterization for PH diagnosis or annual follow-up in the cardiological unit of the university hospital of Poitiers will be included. A venous Doppler ultrasound will be performed by a vascular physician, with experience in vascular ultrasound imaging, within 4 hours before the right heart catheterization. Morphological parameters of vena cava, and velocimetric parameters of femoral, jugular and supra-hepatic veins will be assessed in order to study their correlation with right auricular pressure value.
Eligibility Criteria
You may qualify if:
- Adult patient (age ≥ 18 years old)
- Patient referred to the cardiology department for a right heart catheterization with measurement of RAP, regardless of the indication.
- Free subject, without guardianship or curatorship or subordination
- People affiliated to or beneficiary of a social security schemes
- Informed consent signed by the patient after clear and fair information about the study.
You may not qualify if:
- Minor patient (age \< 18 years)
- Refusal to participate in the study
- Patient with hemodynamic instability, unable to tolerate a delay in treatment caused by the ultrasound examination.
- Patient requiring diuretic treatment within the next 4 hours
- Patient with a life expectancy of less than 24 hours.
- History of proximal deep venous thrombosis involving the inferior vena cava and/or common iliac veins and/or femoral veins.
- History of extrinsic venous compression on the inferior vena cava and/or common iliac veins and/or femoral veins.
- Persons who do not benefit from a Social Security scheme or who do not benefit from it through a third party.
- Persons benefiting from reinforced protection, namely minors, pregnant and nursing women, persons deprived of liberty by a judicial or administrative decision, persons staying in health or social institutions, adults under legal protection and finally patients in emergency situations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Poitiers
Poitiers, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2021
First Posted
March 11, 2021
Study Start
June 14, 2021
Primary Completion
November 21, 2022
Study Completion
November 21, 2022
Last Updated
December 1, 2022
Record last verified: 2022-11